No Association of Plasma Levels of Adiponectin and c-peptide with Risk of Aggressive Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort
暂无分享,去创建一个
[1] M. Kipanyula,et al. Insulin resistance and cancer: the role of insulin and IGFs. , 2013, Endocrine-related cancer.
[2] B. Pierce. Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence. , 2012, Urologic oncology.
[3] C. Mantzoros,et al. The role of adiponectin in cancer: a review of current evidence. , 2012, Endocrine reviews.
[4] M. Thun,et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort , 2002, Cancer.
[5] M. Thun,et al. The American Cancer Society Cancer Prevention Study II Nutrition Cohort , 2002, Cancer.
[6] M. Touvier,et al. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. , 2013, American journal of epidemiology.
[7] S. Freedland,et al. Obesity and prostate cancer: weighing the evidence. , 2013, European urology.
[8] M. Stampfer,et al. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. , 2010, Clinical chemistry.
[9] A. D'Amico,et al. NCCN clinical practice guidelines in oncology: prostate cancer. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[10] Anthony D'Amico,et al. Prostate cancer. Clinical practice guidelines in oncology. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.